Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that Michael Raab, President and CEO, and Justin Renz, chief financial and operations officer, will participate in a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 10:00 A.M. Eastern Time in New York City.

To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ir.ardelyx.com/events-and-presentations. A replay of the panel presentation will be available on the Ardelyx website for 30 days following the event.

About Ardelyx, Inc.
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.

Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com

Staff

Recent Posts

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

1 hour ago

TE Connectivity earns top score from Human Rights Campaign Foundation

2025 Corporate Equality Index assesses LGBTQ+ workplace equality GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ --…

1 hour ago

Education Management Solutions Announces Nominees for 16th Annual Excellence in Clinical Simulation Awards

A Representation of the Best in Simulation Healthcare Education in 2024  ORLANDO, Fla., Jan. 7,…

1 hour ago

University Lab Partners Names Sandra J. Miller as Executive Director to Advance Life Sciences Innovation

Innovation & Entrepreneurship Leader to Accelerate ULP's Mission in Incubation, Acceleration, and Education IRVINE, Calif., Jan.…

1 hour ago

Therap Services Introduces Daily MAR to Enhance Person-Centered Care, allowing Users to Record Medications for Specific Dates

TORRINGTON, Conn., Jan. 7, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

1 hour ago